US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
Open Forum Infectious Diseases (2021) - Comments
pubmed: 34888401  doi: 10.1093/ofid/ofab563  issn: 2328-8957 

Robert W Finberg, Madiha Ashraf, Boris Julg, Folusakin Ayoade, Jai G Marathe, Nicolas C Issa, Jennifer P Wang, Siraya Jaijakul, Lindsey R Baden, Carol Epstein